2025
Treatment exposure-based risk-stratification for care of survivors of childhood cancer: a report from the childhood cancer survivor study
Dinan M, Stratton K, Leisenring W, Yasui Y, Chow E, Tonorezos E, Moskowitz C, Yeh J, Noyd D, Armstrong G, Oeffinger K. Treatment exposure-based risk-stratification for care of survivors of childhood cancer: a report from the childhood cancer survivor study. Journal Of The National Cancer Institute 2025, djaf268. PMID: 40971674, DOI: 10.1093/jnci/djaf268.Peer-Reviewed Original ResearchChildhood Cancer Survivor StudyChronic health conditionsHealth conditionsFive-year survivorsCancer survivorsSurvivor StudyChronic conditionsFive-year survivors of childhood cancerNon-Hispanic white survivorsManagement of childhood cancer survivorsLong-term cancer survivorsSurvivors of childhood cancerChildhood cancer survivorsHigh-risk survivorsSevere chronic conditionsCox proportional hazards modelsSurvivorship clinicRisk of late morbidityWhite survivorsProportional hazards modelHealth careHealth-relatedChildhood cancerHigh-risk groupDiverse populations
2022
T066: Treatment and sex‐specific exposure‐based risk‐stratification for care of survivors of childhood Hodgkin Lymphoma: A report from the Childhood Cancer Survivor Study
Dinan M, Stratton K, Leisenring W, Yasui Y, Chow E, Tonorezos E, Moskowitz C, Yeh J, Noyd D, Armstrong G, Oeffinger K. T066: Treatment and sex‐specific exposure‐based risk‐stratification for care of survivors of childhood Hodgkin Lymphoma: A report from the Childhood Cancer Survivor Study. HemaSphere 2022, 6: 31-31. PMCID: PMC9642057, DOI: 10.1097/01.hs9.0000890832.67877.a2.Peer-Reviewed Original ResearchTreatment exposure-based risk-stratification for care of survivors of childhood cancer: A report from the Childhood Cancer Survivor Study.
Dinan M, Stratton K, Leisenring W, Yasui Y, Chow E, Moskowitz C, Yeh J, Noyd D, Armstrong G, Oeffinger K. Treatment exposure-based risk-stratification for care of survivors of childhood cancer: A report from the Childhood Cancer Survivor Study. Journal Of Clinical Oncology 2022, 40: 10056-10056. DOI: 10.1200/jco.2022.40.16_suppl.10056.Peer-Reviewed Original ResearchChildhood Cancer Survivor StudyHigh-risk groupHigh-risk survivorsCancer Survivor StudyRisk groupsGrade 3Hazard ratioRisk survivorsAge 20Cumulative incidenceChronic conditionsSurvivor StudyChildhood cancerAge 35Treatment exposureLow-risk survivorsFive-year survivorsHigh-risk patientsRisk stratification algorithmConfidence intervalsProportional hazards modelLong-term surveillanceCare of survivorsLate mortalityPrimary endpoint
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply